Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEEET
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,746
Award facts
- Contract value 100% obligated
- $16,745.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,745.74 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on December 15, 2025, with an ultimate completion date of December 18, 2025, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, distributing a comprehensive range of pharmaceutical products and medical consumables to the Department of Defense, including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables spanning oncology treatments, immunosuppressants, emergency medications, and routine pharmaceuticals.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The underlying IDC, designated SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499,999,999 with a completion date of December 31, 2036, structured as a 30-month base period with three 30-month option periods. The PPV-G GEN V contract positions DMS Pharmaceutical Group as one of multiple regional prime vendor contractors authorized to supply the diverse pharmaceutical requirements of Department of Defense military healthcare facilities worldwide, with the contractor demonstrating substantial performance capability across multiple therapeutic categories and product lines.
Quick answers
Who was awarded contract SPE2DU26FEEET?
SPE2DU26FEEET was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DU26FEEET worth?
The government has obligated $16,746 on SPE2DU26FEEET.
Is contract SPE2DU26FEEET an order under another contract?
Yes. SPE2DU26FEEET is a delivery order under SPE2DU25D9439, an indefinite delivery contract.
Was contract SPE2DU26FEEET competed?
The extent of competition for SPE2DU26FEEET was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award